- Home
- PHM vs WAT Comparison
PHM vs WAT Comparison
Compare PHM & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHM
- WAT
- Stock Information
- Founded
- PHM 1950
- WAT 1958
- Country
- PHM United States
- WAT United States
- Employees
- PHM N/A
- WAT N/A
- Industry
- PHM Homebuilding
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- PHM Consumer Discretionary
- WAT Industrials
- Exchange
- PHM Nasdaq
- WAT Nasdaq
- Market Cap
- PHM 20.5B
- WAT 21.9B
- IPO Year
- PHM N/A
- WAT 1995
- Fundamental
- Price
- PHM $103.04
- WAT $356.03
- Analyst Decision
- PHM Buy
- WAT Buy
- Analyst Count
- PHM 16
- WAT 15
- Target Price
- PHM $138.13
- WAT $397.47
- AVG Volume (30 Days)
- PHM 2.3M
- WAT 456.9K
- Earning Date
- PHM 04-22-2025
- WAT 05-06-2025
- Dividend Yield
- PHM 0.85%
- WAT N/A
- EPS Growth
- PHM 25.30
- WAT N/A
- EPS
- PHM 14.69
- WAT 10.71
- Revenue
- PHM $17,946,950,000.00
- WAT $2,958,387,000.00
- Revenue This Year
- PHM $1.83
- WAT $5.06
- Revenue Next Year
- PHM $5.91
- WAT $6.53
- P/E Ratio
- PHM $7.01
- WAT $33.23
- Revenue Growth
- PHM 11.74
- WAT 0.07
- 52 Week Low
- PHM $99.58
- WAT $279.24
- 52 Week High
- PHM $149.47
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- PHM 44.92
- WAT 39.14
- Support Level
- PHM $99.58
- WAT $355.00
- Resistance Level
- PHM $106.94
- WAT $377.52
- Average True Range (ATR)
- PHM 2.81
- WAT 11.40
- MACD
- PHM 0.04
- WAT -0.76
- Stochastic Oscillator
- PHM 43.58
- WAT 5.52
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.